Sorted By:

Relevance


Focusing on Only 1% of Spending Will Not Solve Nation’s Health Care Challenges

PhRMA  |  Blog Post

Today, there are almost 14 million cancer survivors in the U.S. and the chances that a cancer patient will live five years or more has increased by 39 percent across all cancers.
http://catalyst.phrma.org/focusing-on-only-1-of-spending-will-not-solve-nations-health-care-challenges

PhRMA Honors Patient Advocates Ron and Raychel Bartek

PhRMA  |  Press Release

The illnesses being targeted by current rare disease research include rare cancers, autoimmune disorders and cardiovascular disorders.
https://www.phrma.org/press-release/phrma-honors-patient-advocates-ron-and-raychel-bartek

Medicines in Development For Skin Diseases

PhRMA  |  Press Release

They include: • 74 for skin cancers, including 63 for melanoma, which affects more than 68,000 Americans each year and is the most common form of cancer in the United States.
https://www.phrma.org/press-release/medicines-in-development-for-skin-diseases

New PhRMA report: More than 170 medicines in development for diabetes offer patients longer, healthier lives

PhRMA  |  Blog Post

Bill Chin, where he tells the story of diagnosing his son with type 1 diabetes and how his family and his professional career have both informed his perspective on the disease.
http://catalyst.phrma.org/new-phrma-report-more-than-170-medicines-in-development-for-diabetes-offer-patients-longer-healthier-lives

Research doesn’t end on a medicine’s approval

PhRMA  |  Blog Post

Oncology therapies often have clinical value in types of cancers distinct from the original indication(s) for which they are approved.
http://catalyst.phrma.org/research-doesnt-end-on-a-medicines-approval

Ask About Adherence: Q&A with PhRMA Foundation Young Investigator Adherence Grantee - Xian Shen

PhRMA  |  Blog Post

DOUGHERTY: How has/will the PhRMA Foundation grant advance your career in adherence research?
http://catalyst.phrma.org/ask-about-adherence-–-qa-with-phrma-foundation-young-investigator-adherence-grantee-xian-shen

What 60 Minutes Missed on the Value and Cost of Cancer Medicines

PhRMA  |  Blog Post

PAGE: Read More About Medicines in Development for Cancer REPORT: Nearly 800 New Medicines and Vaccines in Clinical Testing for Cancer (2014) VIDEOS: I'm Not Average Cancer Patients Share Their Stories REPORT: Researching Cancer Medicines: Setbacks and Stepping Stones NEWS RELEASE: Researching Cancer Medicines: Setbacks and Stepping Stones
http://catalyst.phrma.org/what-60-minutes-missed-on-the-value-and-cost-of-cancer-medicines

Ask About Adherence: Q&A with The Peter Lamy Center for Drug Therapy and Aging

PhRMA  |  Blog Post

  Second, while our subjects were Medicare beneficiaries, the plans providing Part D drug benefits are all commercial insurance carriers.
http://catalyst.phrma.org/ask-about-adherence-qa-with-the-peter-lamy-center-for-drug-therapy-and-aging

Team PhRMA Raises $100,000 for Leukemia/Lymphoma Research

PhRMA  |  Press Release

The discussion will explore the exciting promise of medicines in the pipeline for blood cancers, the often incremental nature of cancer research and its role in improving patient health, barriers to future progress, and the importance of constructive partnerships to continued innovation.
https://www.phrma.org/press-release/team-phrma-raises-100-000-for-leukemia/lymphoma-research

Patience, Hope and Survival: Progress on the Cancer Front

PhRMA  |  Blog Post

The 5-year survival rate for all cancers was 38 percent in the late 1960s and today it is an astonishing 68 percent.
http://catalyst.phrma.org/patience-hope-and-survival-progress-on-the-cancer-front

Partnership for Prescription Assistance Celebrates Milestone Helping More Than 6 Million Uninsured Patients

PhRMA  |  Press Release

For the rest of his career, Bettis says he made a stronger effort to “manage and monitor myself to make sure that I was in the right condition in order to be able to play.”
https://www.phrma.org/press-release/partnership-for-prescription-assistance-celebrates-milestone-helping-more-than-6-million-uninsured-patients

PhRMA Statement on Clinical Trials and Bad Pharma

PhRMA  |  Press Release

Medicines tested through the clinical trial process have contributed to dramatically reduced death rates (including a 79 percent reduction in deaths from HIV/AIDS, a 30 percent decrease in deaths from heart disease and a 20 percent decrease in deaths from cancers).
https://www.phrma.org/press-release/phrma-statement-on-clinical-trials-and-bad-pharma

Medicines in Development for Vaccines

PhRMA  |  Press Release

HPV can lead to cervical and other cancers.
https://www.phrma.org/press-release/medicines-in-development-for-vaccines

New Report Shows Past Drug Failures Aid in the Fight Against Cancer

PhRMA  |  Blog Post

In the past 16 years, there have been a total of 338 unsuccessful investigational drugs and only 20 FDA-approved medicines across the three cancers.
http://catalyst.phrma.org/new-report-shows-past-drug-failures-aid-in-the-fight-against-cancer

ICYMI: New Report on Benefits of Cancer Medicines That Emerge After FDA Approval

PhRMA  |  Blog Post

Increasing understanding of the underlying biology of the disease is also revealing that many cancer medicines are useful in other types of cancers besides the one they were originally approved to treat.
http://catalyst.phrma.org/icymi-new-report-on-benefits-of-cancer-medicines-that-emerge-after-fda-approval

The Industry-Labor Partnership: Where Biopharmaceutical Innovation Meets Economic Advancement

PhRMA  |  Blog Post

In fact, in many locations, nearly 25% of the apprentices have four-year degrees – they have come for career training they could not get with a Bachelor of Arts degree.
http://catalyst.phrma.org/the-industry-labor-partnership-where-biopharmaceutical-innovation-meets-economic-advancement

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

PhRMA’s own Sharon Brigner noted she’s found a rewarding career advocating for patients at the bedside and at the policy table.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma

More Than 450 Innovative Medicines in Development for Rare Diseases

PhRMA  |  Press Release

The 452 medicines and vaccines in development for rare diseases – all in human clinical trials or under review by the FDA – include 105 for cancer, 85 for genetic disorders, 65 for blood cancers and 32 for neurological disorders.
https://www.phrma.org/press-release/more-than-450-innovative-medicines-in-development-for-rare-diseases

Nearly 800 New Medicines in Development to Help in the Fight Against Cancer

PhRMA  |  Press Release

Researchers are also identifying ways to use existing medicines, either alone or in combination with other therapies, to treat various types of cancers more effectively than current standards of care. 
https://www.phrma.org/press-release/nearly-800-new-medicines-in-development-to-help-in-the-fight-against-cancer

Rare Diseases: Target Practice

From Hope To Cures  |  From Our Network

Additionally, atypical cancers represent the biggest target for orphan drugs.
http://www.fromhopetocures.org/rare-diseases-target-practice

Celgene’s Robert J. Hugin Becomes PhRMA Board Chairman

PhRMA  |  Press Release

He began his career with Pfizer in 1978 as an operational auditor.
https://www.phrma.org/press-release/celgene-s-robert-j-hugin-becomes-phrma-board-chairman

Ask About Adherence: Q&A with PhRMA Foundation Young Investigator Adherence Grantee - Sujit S. Sansgiry

PhRMA  |  Blog Post

DOUGHERTY: How has/will the PhRMA Foundation grant advance your career in adherence research?
http://catalyst.phrma.org/ask-about-adherence-qa-with-phrma-foundation-young-investigator-adherence-grantee-sujit-s.-sansgiry

More Than 850 Medicines in Development For Diseases that Disproportionately Strike Women

PhRMA  |  Press Release

The number includes 139 for cancers that affect women and 110 for autoimmune diseases, which strike women three times more often than men.
https://www.phrma.org/press-release/more-than-850-medicines-in-development-for-diseases-that-disproportionately-strike-women

PhRMA Statement on the FDA Approving Biosimilars

PhRMA  |  Press Release

As of 2008, more than 300 biologics had been approved by the Food and Drug Administration (FDA) and 633 biotechnology medicines were in development, including more than 250 for various cancers.
https://www.phrma.org/press-release/phrma-statement-on-the-fda-approving-biosimilars

World Cancer Day: Reflecting on progress and hope for the future in cancer treatment

PhRMA  |  Blog Post

And researchers are continuing to better understand the inner workings and underlying mechanisms of cancers every day.
http://catalyst.phrma.org/world-cancer-day-reflecting-on-progress-and-hope-for-the-future-in-cancer-treatment

You have reviewed the first 225 results out of 263. Each page contains 25 results. You're on page 9.

prev 7 8 9 10 11 next